Naveed Sattar

Professor of Metabolic Medicine

University of Glasgow

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Naveed Sattar is a faculty member at the University of Glasgow, UK, specializing in Metabolic Medicine. His research focuses on cardiometabolic health, including the management of cardiovascular disease in diabetes patients, obesity-related health parameters, and insulin resistance in different demographics. He has contributed significantly to understanding factors associated with elevated inflammatory markers and the risks of dementia among individuals with diabetes.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (24)

John Mathers

Professor of Human Nutrition

Newcastle University

UNITED KINGDOM

Naveed Sattar

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Factors Associated with Elevated High-Sensitivity C-Reactive Protein Levels in Individuals with Atherosclerotic Cardiovascular Disease in the US and the UK

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence

Differences in tissue-specific insulin resistance between South Asian and Nordic women with prediabetes after gestational diabetes

Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study

Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings

Body mass index and infection risks in people with and without type 2 diabetes: A cohort study using electronic health records

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019

Response by Ho et al to Letter Regarding Article, “A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia”

Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2

Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence

Response to "Importance of method assumptions".

Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial

Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019

In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C‐reactive protein?

Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐O trial

Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank

Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study

Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland

Low thiamine status in adults following low-carbohydrate / ketogenic diets: a cross-sectional comparative study of micronutrient intake and status

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

Neighbourhood‐level social deprivation and the risk of recurrent heart failure hospitalizations in type 2 diabetes

Efficacy and Safety of Empagliflozin According to Background Diuretic Use in Heart Failure With Reduced Ejection Fraction

Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis

Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank (N = 39 283)

A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects

Association between walking pace and incident type 2 diabetes by adiposity level: A prospective cohort study from the UK Biobank

Associations of grip strength and walking pace with mortality in stroke survivors: A prospective study from UK Biobank

Collaborators (24)

John Mathers

Hiddo Lambers Heerspink

Nicholas Timpson

Frederick Ho

Salil Deo

Ewan Forrest

Bianca Rocca

Nazim Ghouri

Paul Welsh

Kamlesh Khunti

Matthew Lee

Donald M. Lyall

Kaitlin Wade

Fu Siong Ng

Carolyn SP Lam

Fanny Peterman‐Rocha

James Januzzi

Ramzi Ajjan

Carlos Celis‐Morales

Elisabeth Qvigstad

Kausik Ray

Alexandra Kautzky-Willer

Stuart Gray

William Herrington

Make your next move.